Morgan Stanley analysts have estimated that Lilly’s GLP-1 pill could bring in as much as $40 billion in annual sales by 2033.

EchoStar’s 5G ambitions go back to 2019, and are the byproduct of another major telecom deal: T-Mobile’s acquisition of ...

On Tuesday, the elder statesman of America’s tech giants announced it will partner with semiconductor powerhouse AMD to ...

Cash is king, but income-generating mutual funds and ETFs are increasingly being used for clients, Nasdaq found.

There isn’t an ETF for everything, but the volume of leveraged products coming to market shows a strategy of filling any ...

As AI continues to rake in funds despite questions about long-term profitability, some experts are calling for more ...